Consensus Interferon: A novel interferon for the treatment of hepatitis C

Journal of Viral Hepatitis

Volumn 5, Issue SUPPL. 1, 1998, Pages 13-18

  Heathcote, J ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Consensus interferon; Hepatitis C; Relapsers non responders

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ALPHA2A INTERFERON; ALPHA2B INTERFERON; CONSENSUS INTERFERON; UNCLASSIFIED DRUG; VIRUS RNA;

ADULT; ANTIVIRAL ACTIVITY; BINDING AFFINITY; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG SAFETY; FEMALE; HELA CELL; HEPATITIS C; HUMAN; HUMAN CELL; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; ALANINE TRANSAMINASE; DOUBLE-BLIND METHOD; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON TYPE I, RECOMBINANT; INTERFERON-ALPHA; MALE; RETREATMENT; RNA, VIRAL;

EID: 0031721477     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.1998.0050s1013.x     Document Type: Article

References (8)

1. Pestka SS et al. Interferon and their actions. Annu Rev Biochem 1987; 56: 727-77.
2. Gewert D et al. Antiviral effects of interferons: studies in animals and at the cellular level. Baron S et al. (eds) In: Interferon Principles and Medical Applications. Galveston: University of Texas Medical Branch, Dept of Microbiology 1992; 289-297.
3. Blatt LM et al. The biological activity and molecular characterization of a novel synthetic interferon-alpha species, consensus interferon. J Interferon Cytokine Res 1996; 16: 489-99.
4. Alton K et al. Production, characterization and biological effects of recombinant DNA derived human IFN-α and IFN-γ analogs. In: De Maeyer E et al. (eds) the Biology of the Interferon System. Amsterdam: Elsevier Science Publishers 1983; 119-128.
5. Ozes ON et al. A comparison of interferon-con1 with natural recombinant interferons-α: anti viral, antiproliferative and natural killer-inducing activities. J Interferon Res 1992; 12: 55-99.
6. Klein SB et al. Consensus interferon induces peak mRNA accumulation at lower concentrations than interferon-α2a. J Interferon Res 1993; 13: 341-7.
7. Tong MJ et al. Treatment of chronic hepatitis C with consensus interferon: a multicentre, randomized controlled trial. Hepatology 1998; 26: 747-54.
8. Heathcote EJL et al. Retreatment of chronic hepatitis C with consensus interferon. Hepatology 1998; 27: 1136-43.